TABLE 2.
Baseline clinical characteristics across included studies.
| References | Study arm | Age (y) | Gender (male, %) | eGFR (mL/min/1.73 m2) | SCr (mg/dL) | HTN (%) |
DM (%) |
CKD (%) |
HF (%) |
Prior PCI (%) |
| Desch et al. (27) | DyeVert | 69 ± 14 | 58 | NR | NR | 73 | 13 | 69 | 42 | 23 |
| Control | 66 ± 13 | 58 | NR | NR | 71 | 17 | 77 | 40 | 27 | |
| Bath et al. (29) | DyeVert | NR | NR | NR | NR | NR | NR | 100 | NR | NR |
| Control | NR | NR | NR | NR | NR | NR | 100 | NR | NR | |
| Briguori et al. (30) | DyeVert | 63 ± 13 | 71 | 74 ± 26 | 1.0 (0.8–1.1) |
61 | 22 | 30 | NR | NR |
| Control | 64 ± 13 | 77 | 79 ± 28 | 1.0 (0.8–1.2) |
62 | 18 | 23 | NR | NR | |
| Sattar et al. (31) | DyeVert | 69 | 41 | 43.6 | 1.6 | 90 | 54 | 100 | NR | NR |
| Control | 71 | 65 | 47.7 | 1.5 | 93 | 51 | 100 | NR | NR | |
| Kutschman (32) | Overall | 69 ± 11 | 57 | 43 ± 13 | NR | NR | NR | 100 | NR | NR |
| Kutschman et al. (33) | Overall | 64 ± 32 | 63 | 64 ± 32 | 1.6 ± 1.6 | 82 | 55 | 33 | 23 | 27 |
| Bunney et al. (34) | DyeVert | 63 | NR | NR | NR | NR | 72 | 55 | 28 | NR |
| Control | 61 | NR | NR | NR | NR | 48 | 24 | 15 | NR | |
| Tajti et al. (35) | DyeVert | 68 ± 9 | 82 | 72 (55–83) |
1.1 (0.9–1.2) |
90 | 49 | NR | 21 | 72 |
| Control | 66 ± 12 | 78 | 77 (57–89) |
1.0 (0.9–1.2) |
83 | 42 | NR | 20 | 63 | |
| Zimin et al. (36) | DyeVert | 67 ± 11 | 79 | 71 ± 20 | 1.0 ± 0.3 | 86 | 50 | 7 | 14 | 57 |
| Sapontis et al. (37) | DyeVert | 69 ± 11 | 68 | NR | NR | 75 | 34 | 43 | 18 | 36 |
| Corcione et al. (38) | DyeVert | 66 ± 12 | 80 | 81 ± 20 | 1.0 ± 0.2 | NR | NR | 30 | NR | NR |
| Gurm et al. (39) | DyeVert | 72 ± 9 | 72 | 43 ± 11 | 1.6 ± 0.5 | 96 | 53 | 100 | 47 | 53 |
| Turner and Tucker (40) | Overall | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Cameron and Espinosa (41) | Overall | NR | NR | NR | NR | NR | NR | 24 | NR | NR |
| Rao (42) | DyeVert | 66 ± 13 | 43 | 46 ± 29 | 1.6 ± 0.6 | 71 | 86 | 86 | 57 | 14 |
| Amoroso et al. (43) | DyeVert | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Bruno et al. (28) | DyeVert | 71 ± 10 | 56 | 72 ± 9 | 1.2 ± 0.4 | 78 | 44 | NR | 67 | NR |
Data presented are mean ± standard deviation, median (IQR), or %.
CKD, chronic kidney disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HF, heart failure; HTN, hypertension; NR, not reported; PCI, percutaneous coronary intervention; SCr, serum creatinine.